Diphenhydramine

Generic Name
Diphenhydramine
Brand Names
Acetadryl, Advil PM, Aleve PM, Allegra Cooling Relief Anti-itch, Banophen, Benadryl, Benadryl Itch Stopping, Benadryl-D Allergy and Sinus, Calagel, Damylin With Codeine, Dimetapp Nighttime Cold & Congestion, Diphen, Diphenhist, Diphenist, Excedrin PM Triple Action, Goody's PM, Legatrin PM, Motrin PM, Nytol, Nytol Quickgels, Percogesic Reformulated Jan 2011, Siladryl, Simply Sleep, Sleepinal, Sominex, Triaminic Night Time Cold & Cough, Tylenol PM, Unisom, Unisom Sleep, Vanamine, Wal-dryl, Wal-som (doxylamine), Zzzquil
Drug Type
Small Molecule
Chemical Formula
C17H21NO
CAS Number
58-73-1
Unique Ingredient Identifier
8GTS82S83M
Background

Diphenhydramine - perhaps known most commonly as its brand name formulation Benadryl - is a first-generation H1 receptor antihistamine that is used extensively for the treatment of seasonal allergies, insect bites and stings, and rashes . However, it also has antiemetic, antitussive, hypnotic, and antiparkinson properties . As histamine receptors exist both ...

Indication

Diphenhydramine is a first-generation histamine H1 receptor antagonist (H1 antihistamine) that is widely available as a non-prescription, over-the-counter (OTC) medication. As an OTC medication, diphenhydramine is typically formulated as tablets and creams indicated for use in treating sneezing, runny nose, itchy/watery eyes, itching of nose or throat, insom...

Associated Conditions
Allergic Reaction, Allergic Rhinitis (AR), Allergic cough, Allergy to Tree Pollen, Anaphylaxis, Angioedema, Common Cold, Conjunctival irritation, Cough, Cough Variant Asthma, Cough caused by Common Cold, Eye allergy, Fever, Insect Bites, Insect Stings, Insomnia, Irritative cough, Itching of the nose, Itching of the throat, Motion Sickness, Nasal Congestion, Oral Mucositis, Pain, Parkinsonian Syndromes, Productive cough, Pruritus, Rash, Rhinorrhoea, Sinus Congestion, Sinus headache, Skin Irritation, Sneezing, Sunburn, Symptoms of Acute Bronchitis Accompanied by Coughing, Upper respiratory tract hypersensitivity reaction, site unspecified, Urticaria, Cold or flu syndrome, Dermatographism, Dry cough, Watery itchy eyes
Associated Therapies
Airway secretion clearance therapy, Expectorant

Diphenhydramine as an Adjunctive Sedative in Patients on Chronic Opioids

First Posted Date
2013-10-22
Last Posted Date
2020-03-11
Lead Sponsor
University of Oklahoma
Target Recruit Count
120
Registration Number
NCT01967433
Locations
🇺🇸

Veterans Affairs Medical Center, Oklahoma City, Oklahoma, United States

First-time-in-man, to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BP1.5375

First Posted Date
2013-10-18
Last Posted Date
2015-01-21
Lead Sponsor
Bioprojet
Target Recruit Count
48
Registration Number
NCT01965301
Locations
🇳🇱

Centre for Human Drug Research, Leiden, Netherlands

Intrathecal Levobupivacaine With Opioids for Caesarean Section

First Posted Date
2013-05-21
Last Posted Date
2013-05-21
Lead Sponsor
Baskent University
Target Recruit Count
93
Registration Number
NCT01858090
Locations
🇹🇷

Baskent University School of Medicine Adana Teaching and Research Hospital, Adana, Turkey

Morphine Mouthwash for Management of Oral Mucositis in Patients With Head and Neck Cancer

First Posted Date
2013-04-23
Last Posted Date
2013-04-23
Lead Sponsor
Isfahan University of Medical Sciences
Target Recruit Count
30
Registration Number
NCT01837446
Locations
🇮🇷

Radiation Oncology Department, Seyed Al-Shohada Hospital, Isfahan, Iran, Islamic Republic of

Diphenhydramine for Acute Migraine

First Posted Date
2013-04-08
Last Posted Date
2018-07-31
Lead Sponsor
Montefiore Medical Center
Target Recruit Count
208
Registration Number
NCT01825941
Locations
🇺🇸

Montefiore Medical Center, Bronx, New York, United States

Randomized Trial of Diphenhydramine Versus Continued Midazolam in "Difficult-to-sedate" Patients Undergoing Colonoscopy

Not Applicable
Completed
Conditions
Interventions
First Posted Date
2013-01-16
Last Posted Date
2017-02-10
Lead Sponsor
VA Connecticut Healthcare System
Target Recruit Count
200
Registration Number
NCT01769586
Locations
🇺🇸

VA Connecticut Healthcare System, West Haven, Connecticut, United States

Effect of P-glycoprotein Inhibition on Lenalidomide Pharmacokinetics in Healthy Males

First Posted Date
2012-10-24
Last Posted Date
2019-11-08
Lead Sponsor
Celgene
Target Recruit Count
31
Registration Number
NCT01712828
Locations
🇺🇸

Covance Clinical Research Unit Dallas, Dallas, Texas, United States

The Role of Intravenous (IV) Lidocaine in the Management of Chronic Neuropathic Pain of Peripheral Nerve Origin

Not Applicable
Completed
Conditions
Interventions
First Posted Date
2012-08-21
Last Posted Date
2019-03-15
Lead Sponsor
Lawson Health Research Institute
Target Recruit Count
34
Registration Number
NCT01669967
Locations
🇨🇦

St. Joseph's Health Care, London, Ontario, Canada

TUSC2-nanoparticles and Erlotinib in Stage IV Lung Cancer

First Posted Date
2011-10-20
Last Posted Date
2022-03-02
Lead Sponsor
Genprex, Inc.
Target Recruit Count
25
Registration Number
NCT01455389
Locations
🇺🇸

UT MD Anderson Cancer Center, Houston, Texas, United States

© Copyright 2024. All Rights Reserved by MedPath